Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
A Janus kinase (JAK) inhibitor helped preserve beta-cell function in people with recent-onset type 1 diabetes, the phase II BANDIT trial found. Meeting the study's primary endpoint, daily baricitinib ...
News-Medical.Net on MSN
Scientists revive diabetic beta cells, revealing a new path to restore insulin function
Researchers demonstrated that pancreatic β cells from type 2 diabetes donors can partially regain glucose responsiveness when ...
Please provide your email address to receive an email when new articles are posted on . The thiazolidinedione pioglitazone and GLP-1 receptor agonists are the only two diabetes drugs proved to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback